WASHINGTON, May 19 -- International Trade Commission has issued a notice called: Certain Drug Products Containing C-Type Natriuretic Peptide Variants, and Components Thereof; Notice of a Commission Determination Not To Review an Initial Determination Amending the Complaint and Notice of Investigation.
The notice was published in the Federal Register on May 19 by Sharon Bellamy, Supervisory Hearings and Information Officer.
Summary: Notice is hereby given that the U.S. International Trade Commission ("Commission") has determined not to review an initial determination ("ID") (Order No. 45) of the presiding Chief administrative law judge ("Chief ALJ") granting complainant's unopposed motion to amend the complaint and notice of investigation ...